Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 2, June

Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy

Volume:2   Issue: 2
Pp: 91-102
I. A.J. Lorimer
DOI: 10.2174/1568009023333926
Published on: 01 March, 2012

Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan

Volume:2   Issue: 2
Pp: 103-123
Ron H.J. Mathijssen, Walter J. Loos, Jaap Verweij and Alex Sparreboom
DOI: 10.2174/1568009023333890
Published on: 01 March, 2012

Protein Kinase C-θ (PKCθ), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias

Volume:2   Issue: 2
Pp: 125-134
Martin Villalba and Amnon Altman
DOI: 10.2174/1568009023333908
Published on: 01 March, 2012

Clinical Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor and Its Receptors as Cancer Therapeutics

Volume:2   Issue: 2
Pp: 135-156
Zhenping Zhu, Peter Bohlen and Larry Witte
DOI: 10.2174/1568009023333881
Published on: 01 March, 2012

Chromatin (dis)Organization and Cancer: BUR-binding Proteins as Biomarkers for Cancer

Volume:2   Issue: 2
Pp: 157-190
Sanjeev Galande
DOI: 10.2174/1568009023333917
Published on: 01 March, 2012